Search
for
Sort by
Research 871–900 of 1000+
- Topische Immuntherapie mit Diphenylcyclopropenon bei verschiedenen Typen der Alpecia areata: Assoziation zu klinischen Parametern und einem funktionellen Genpolymorphismus des Interleukin-6-Promotors
- Abstracts
- British Society for Dermatopathology: Summaries of Papers
- CME examination for volume 43
- National scientific medical meeting 1996 abstracts
- Psoriasis
- Cutaneous signals of immune system disease
- The role of integrin alphavbeta6 in impaired wound healing and hair follicle regeneration
- Hypersensitivity Reactions to Anticoagulant Drugs
- Effect of bioclimatic area and season on phenolics and antioxidant activities of rosemary (<i>Rosmarinus officinalis</i> L.) leaves
- A systematic review of dermatologic manifestations among adult patients with COVID‐19 diagnosis
- Dermatologic Conditions of the Early Post-Transplant Period in Hematopoietic Stem Cell Transplant Recipients
- Efficacy and Tolerability of Brevilin-A, a Natural JAK Inhibitor, in Pediatric Alopecia Areata: A Case Series
- Serum level of vitamin D in patients with alopecia areata
- 186 Mechanistic insights into Ritlecitinib-mediated immunomodulation in Alopecia Areata
- Increased CRHR1 expression on monocytes from patients with AA enables a pro‐inflammatory response to corticotrophin‐releasing hormone
- ROS-responsive hydrogel-delivered miR-665 targets STAT3 to alleviate inflammation and promote hair follicle regeneration in alopecia areata
- ROS-responsive hydrogel-delivered miR-665 targets STAT3 to alleviate inflammation and promote hair follicle regeneration in alopecia areata
- A Real-World Study of Steroid-Free Monotherapy with Tofacitinib in Severe and Therapy-Recalcitrant Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Cases: A Retrospective Analysis
- Low-Dose IL-2 for Treating Moderate to Severe Alopecia Areata: A 52-Week Multicenter Prospective Placebo-Controlled Study Assessing its Impact on T Regulatory Cell and NK Cell Populations
- Dermatological complications due to post‑COVID‑19 syndrome: A systematic review
- Immune therapies for alopecia areata: evidence and new perspectives
- Janus kinase inhibitors for alopecia areata: a review of clinical data
- Systemic Tofacitinib in Alopecia Areata: A Single Center Retrospective Descriptive Cohort Study
- Gene Expression of CD70 and CD27 Is Increased in Alopecia Areata Lesions and Associated with Disease Severity and Activity
- Evaluation of vitamin D in pediatric alopecia areata: A case–control study of thirty patients in a tertiary care hospital
- Resident T cell activation leads to human hair follicle immune privilege loss ex vivo, which is prevented by the DHODH inhibitor farudodstat: relevance for alopecia areata
- Successful Treatment of Coexisting Alopecia Areata and Bullous Pemphigoid With Dupilumab: A Case Report
- 022 Exploring the potential of the novel IFNγ aptamer TAGX-0003 as a treatment for alopeciaareata in pre-clinical models
- 229 Single cell transcriptomics identifies a potential role for Arg1+ macrophages in alopecia areata pathogenesis